C.Harry Kent
Impact in
-
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
- Neutropenia and Cancer Infections
-
- Neuroendocrine Tumor Research Advances
Papers in
- Oncology 4
- Lung Cancer Research Studies 3
- Peptidase Inhibition and Analysis 3
- Colorectal Cancer Surgical Treatments 1
-
- Heart Failure Treatment and Management 2
- Co-authors
- RalphE. Johnson (2 shared papers)Ralph E. Johnson (2 shared papers)Harmar D. Brereton (2 shared papers)Michael Busch-Sørensen (1 shared paper)Maria K Iachina (1 shared paper)Simon G Ray (1 shared paper)Knut Stavem (1 shared paper)Terje Rolf Pedersen (1 shared paper)
- Journals
- The Lancet (4 papers)The Annals of Thoracic Surgery (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)The American Journal of Cardiology (1 paper)
- Partner nations
- United StatesMalaysiaDenmark
In The Last Decade
C.Harry Kent
7 papers receiving 215 citations
C.Harry Kent's Hit Papers
Peers
Comparison fields: 5 of 36
- Oncology 177
- Epidemiology 134
- Pulmonary and Respiratory Medicine 83
- Neurology 25
- Cardiology and Cardiovascular Medicine 30
Countries citing papers authored by C.Harry Kent
This map shows the geographic impact of C.Harry Kent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.Harry Kent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.Harry Kent more than expected).
Fields of papers citing papers by C.Harry Kent
This network shows the impact of papers produced by C.Harry Kent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.Harry Kent. The network helps show where C.Harry Kent may publish in the future.
Co-authors
The 17 scholars most cited alongside C.Harry Kent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1976 | 93 | |
| 2 | 1978 | 63 | |
| 3 | 1977 | 35 | |
| 4 | Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial Hit paper breakdown → | 2025 | 30 |
| 5 | 2014 | 21 | |
| 6 | 1976 | 18 | |
| 7 | 2025 | 14 |
About C.Harry Kent
C.Harry Kent is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Epidemiology, Surgery and Pulmonary and Respiratory Medicine, having authored 7 papers that have together received 274 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (3 papers), Lung Cancer Research Studies (3 papers), Peptidase Inhibition and Analysis (3 papers), Heart Failure Treatment and Management (2 papers), Anorectal Disease Treatments and Outcomes (1 paper), Lipoproteins and Cardiovascular Health (1 paper), Colorectal Cancer Surgical Treatments (1 paper) and Colorectal and Anal Carcinomas (1 paper). The work is most often cited by research in Oncology (177 citations), Epidemiology (134 citations), Pulmonary and Respiratory Medicine (83 citations), Neurology (25 citations) and Cardiology and Cardiovascular Medicine (30 citations). C.Harry Kent has collaborated with scholars based in United States, Malaysia and Denmark. Frequent co-authors include RalphE. Johnson, Ralph E. Johnson, Harmar D. Brereton, Michael Busch-Sørensen, Maria K Iachina, Simon G Ray, Knut Stavem, Terje Rolf Pedersen, Anders Green and Ronnie B Willenheimer. Their work appears in journals such as The Lancet, The Annals of Thoracic Surgery, International Journal of Radiation Oncology*Biology*Physics and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.